Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Needs More Public Interest Representatives: Council
August 1, 2005
- Kenporen Presents Its Own Proposal for Healthcare Reform
August 1, 2005
- Differences Between FDA and PMDA Discussed: Symposium
August 1, 2005
- REGULATORY NEWS IN BRIEF
August 1, 2005
- Tsumura Announces New 3-Year Management Plan
August 1, 2005
- Nichi-iko to Do More Business through Wholesalers, Sell More to DPC Hospitals
August 1, 2005
- Parexel Working to Expand Business in Japan
August 1, 2005
- Asahi Kasai Publishes FY2004 Report on Intellectual Properties
August 1, 2005
- JGPMA to Beef Up Preparations for Formal Membership in IGPA
July 25, 2005
- 7th ICAAP Reviews Anti-AIDS Measures
July 25, 2005
- JRCS to Test Joint Purchasing
July 25, 2005
- Generic Drug Request Card Welcomed: JSGM
July 25, 2005
- Taisho Pharm. Ind. Opens New R&D Facility in Koga
July 25, 2005
- Chugai: Strong Growth in 1st-Half Sales, Profits
July 25, 2005
- Trehalose Prevents Postoperative Adhesion: UT Researchers
July 25, 2005
- SSP to Strengthen Focus on Women's Health and Beauty
July 25, 2005
- Applied Price Bargaining Method Proposed by JPMA
July 25, 2005
- Taisho Announces Business, Capital Tie-up with Yomeishu Seizo
July 25, 2005
- Problems with Adjustment of Prices Based on Overseas Prices Must Be Solved Quickly: Dr Hayakawa
July 25, 2005
- Kobayashi Pharm to Launch 7 New Products in Aug.-Oct.
July 25, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…